Supplementary Table 1.
Correlation between lncRNAs expression and clinicopathological features in CRC plasma.
| Clinicopathological factor | Total | RP11-296E3.2 | χ2 | P value | LEF1-AS1 | χ2 | P value | ||
|---|---|---|---|---|---|---|---|---|---|
| Positive | Negative | Positive | Negative | ||||||
| Sex | |||||||||
| Male | 37 | 11 | 26 | 1.856 | 0.173 | 20 | 17 | 0.222 | 0.637 |
| Female | 21 | 10 | 11 | 10 | 11 | ||||
| Age | |||||||||
| <60 years | 26 | 12 | 14 | 2.019 | 0.155 | 14 | 12 | 0.085 | 0.771 |
| ≥60 years | 32 | 9 | 23 | 16 | 16 | ||||
| Tumor size | |||||||||
| <5 cm | 33 | 12 | 21 | 0.056 | 0.813 | 18 | 15 | 0.115 | 0.734 |
| ≥5 cm | 24 | 8 | 16 | 12 | 12 | ||||
| Lymph node metastasis | |||||||||
| Presence | 29 | 14 | 15 | 3.658 | 0.056 | 17 | 12 | 1.105 | 0.293 |
| Absence | 29 | 7 | 22 | 13 | 16 | ||||
| CEA | |||||||||
| Poor | 13 | 4 | 9 | 0.215 | 0.643 | 2 | 9 | 6.893 | 0.009** |
| Well/moderate | 45 | 17 | 28 | 28 | 17 | ||||
| Ca199 | |||||||||
| Poor | 53 | 20 | 33 | 0.622 | 0.430 | 27 | 25 | 0.119 | 0.730 |
| Well/moderate | 5 | 1 | 4 | 3 | 2 | ||||
| E-cad | |||||||||
| Poor | 31 | 16 | 15 | 5.858 | 0.016* | 15 | 16 | 0.234 | 0.628 |
| Well/moderate | 18 | 3 | 15 | 10 | 8 | ||||
| CD44-V6 | |||||||||
| Poor | 40 | 17 | 23 | 1.273 | 0.259 | 20 | 20 | 0.091 | 0.763 |
| Well/moderate | 9 | 2 | 7 | 5 | 4 | ||||
| Ki67 | |||||||||
| ≥0.7 | 34 | 11 | 23 | 0.528 | 0.467 | 20 | 14 | 1.658 | 0.198 |
| <0.7 | 24 | 10 | 14 | 10 | 14 | ||||
P value less than 0.05;
P value less than 0.01.